Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz H Messerli

Showing results (1-10 of 421) with videos related to

Pageof 43
Sort By:
Journal of the American College of Cardiology|February 7, 2009
The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end pointFranz H Messerli
European Heart Journal|March 20, 2003
The LIFE study: the straw that should break the camel's backFranz H Messerli
Annals of Internal Medicine|April 8, 2004
Effects of losartan in hypertension without vascular diseaseFranz H Messerli
Journal of the American College of Cardiology|January 17, 2025
Renal Denervation: Antihypertensive Therapy or Gizmo Idolatry?Franz H Messerli
Kidney International|January 28, 2005
Risk factors for renal cell carcinoma: hypertension or diuretics?Franz H Messerli
Clinical Cornerstone|April 27, 2005
Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular eventsFranz H Messerli
European Heart Journal|September 3, 2004
TIMPs, MMPs and cardiovascular diseaseFranz H Messerli
Current Hypertension Reports|May 26, 2005
Clinical trials report. Race at ASCOT coming to a haltFranz H Messerli
Journal of the American College of Cardiology|September 20, 2005
Aspirin: a novel antihypertensive drug? Or two birds with one stone?Franz H Messerli
JAMA Cardiology|June 18, 2025
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in HypertensionFranz H Messerli
Pageof 43

Showing results (1-10 of 421) with videos related to

Sort By:
Pageof 43
Journal of the American College of Cardiology|February 7, 2009
The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end pointFranz H Messerli
European Heart Journal|March 20, 2003
The LIFE study: the straw that should break the camel's backFranz H Messerli
Annals of Internal Medicine|April 8, 2004
Effects of losartan in hypertension without vascular diseaseFranz H Messerli
Journal of the American College of Cardiology|January 17, 2025
Renal Denervation: Antihypertensive Therapy or Gizmo Idolatry?Franz H Messerli
Kidney International|January 28, 2005
Risk factors for renal cell carcinoma: hypertension or diuretics?Franz H Messerli
Clinical Cornerstone|April 27, 2005
Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular eventsFranz H Messerli
European Heart Journal|September 3, 2004
TIMPs, MMPs and cardiovascular diseaseFranz H Messerli
Current Hypertension Reports|May 26, 2005
Clinical trials report. Race at ASCOT coming to a haltFranz H Messerli
Journal of the American College of Cardiology|September 20, 2005
Aspirin: a novel antihypertensive drug? Or two birds with one stone?Franz H Messerli
JAMA Cardiology|June 18, 2025
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in HypertensionFranz H Messerli
Pageof 43